Skip to main content

Indomethacin enhancement of lymphocyte responses to phytohemagglutinin in breast, stomach and colorectal cancer patients

The Japanese journal of surgery volume 18, pages 152–157 (1988)Cite this article

Abstract

The effect of indomethacin, a prostaglandin synthetase inhibitor, on lymphocyte responses to phytohemagglutinin (PHA) was studied in 111 breast, stomach and colorectal cancer patients. Indomethacin exerted no mitogenic activity and the ethanol in which the indomethacin was dissolved produced no significant effect on the lymphocyte responses to PHA. Compared with the control group (13 healthy subjects and 30 patients with benign disease), indomethacin significantly enhanced the lymphocyte responses to PHA in the cancer patients. The degree of enhancement induced by indomethacin was independent of the primary site of the tumor, but was associated with tumor load. A significant inverse correlation was observed between the degree of enhancement and that of the original lymphocyte responses to PHA. Sequential determinations of the degree of enhancement in selected stomach and colorectal cancer patients revealed that it fell to a low level after curative tumor resection.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Naor D. Suppressor cells: Permitters and promoters of malignancy? Adv Cancer Res 1979; 29: 45–125.

    PubMed  CAS  Article  Google Scholar 

  2. Goodwin JS, Messner RP, Peake GT. Prostaglandin suppression of mitogen-stimulated lymphocytesin vitro: changes with mitogen dose and preincubation. J Clin Invest 1978; 62: 753–760.

    PubMed  CAS  Article  Google Scholar 

  3. Pelus LM, Strausser HR. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int J Cancer 1976; 18: 653–660.

    PubMed  CAS  Google Scholar 

  4. Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, Williams RC. Prostaglandin-producing suppressor cells in Hodgkin’s disease. N Eng J Med 1977; 297: 963–968.

    CAS  Article  Google Scholar 

  5. Vosixa G, Thies J. Effect of indomethacin on blastogenesis of lymphocytes from cancer patients: Differentiation of patients types. Clin Immunol Immunopathol 1979; 13: 30–38.

    PubMed  CAS  Article  Google Scholar 

  6. Han T, Takita H. Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients. Cancer 1980; 46: 2416–2420.

    PubMed  CAS  Article  Google Scholar 

  7. DeShazo RD. Indomethacin-responsive mononuclear cell dysfunction in Hodgkin’s disease. Clin Immunol Immunopathol 1980; 17: 66–75.

    PubMed  CAS  Article  Google Scholar 

  8. Tilden AB, Balch CM. Indomethacin enhancement of immunocompetence in melanoma patients. Surgery 1981; 90: 77–84.

    PubMed  CAS  Google Scholar 

  9. Maca RD, Panje WR. Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and post-irradiation therapy. Cancer 1982; 50: 483–489.

    PubMed  CAS  Article  Google Scholar 

  10. Balch CM, Dougherty PA, Tilden AB. Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients. Ann Surg 1982; 196: 645–650.

    PubMed  CAS  Article  Google Scholar 

  11. Tilden AB, Balch CM. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. Surgery 1982; 92: 528–532.

    PubMed  CAS  Google Scholar 

  12. Han T, Nemoto T, Ledesma EJ, Bruno S. Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients. Int J Immunopharmacol 1983; 5: 11–15.

    PubMed  CAS  Article  Google Scholar 

  13. Balch CM, Dougherty PA, Cloud GA, Tilden AB. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery 1984; 95: 71–77.

    PubMed  CAS  Google Scholar 

  14. McCormick KJ, Panje WR. Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer. Cancer Immunol Immunother 1986; 21: 226–232.

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. The First Department of Surgery, Nihon University, School of Medicine, Oyaguchi, Itabashi, 173, Tokyo, Japan

    Yasuhiko Kurosu MD, Toru Arai & Ken Morita

Authors
  1. Yasuhiko Kurosu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toru Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kurosu, Y., Arai, T. & Morita, K. Indomethacin enhancement of lymphocyte responses to phytohemagglutinin in breast, stomach and colorectal cancer patients. The Japanese Journal of Surgery 18, 152–157 (1988). https://doi.org/10.1007/BF02471424

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02471424

Key Words

  • cancer, indomethacin
  • lymphocyte blastogenesis
  • PHA